España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ALX Oncology Holdings
ALXO
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.62
0.14
9.46%
At close: -
$1.62
-0.00050
-0.03%
After Hours: Dec 20, 4:29 PM EDT
Get Report
Comment
ALX Oncology Holdings (ALXO) Forecast
News
Earnings
ALX Oncology Holdings (ALXO) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ALX Oncology Holdings (NASDAQ:ALXO) Stock
ALX Oncology Holdings Stock (NASDAQ: ALXO)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, December 19, 2024
ALX Oncology shares are trading lower after J...
Benzinga Newsdesk
Jefferies Downgrades ALX Oncology Holdings to...
Benzinga Newsdesk
Wednesday, December 18, 2024
Cantor Fitzgerald Reiterates Overweight on AL...
Benzinga Newsdesk
ALX Oncology To Present Updated Phase 2 ASPEN...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ALX Onc...
Benzinga Newsdesk
Thursday, December 12, 2024
ALX Oncology To Host Virtual Company Event Hi...
Benzinga Newsdesk
Tuesday, December 10, 2024
ALX Oncology Presents New Data Demonstrating ...
Benzinga Newsdesk
Tuesday, November 12, 2024
Cantor Fitzgerald Reiterates Overweight on AL...
Benzinga Newsdesk
Thursday, November 07, 2024
ALX Oncology Holdings Q3 2024 GAAP EPS $(0.58...
Benzinga Newsdesk
Friday, November 01, 2024
ALX Oncology Announces Results From Phase 1b/...
Benzinga Newsdesk
Wednesday, September 04, 2024
ALX Oncology Announces First Patients Dosed W...
Benzinga Newsdesk
Tuesday, August 27, 2024
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
Avi Kapoor
Friday, August 16, 2024
UBS Maintains Buy on ALX Oncology Holdings, L...
Benzinga Newsdesk
Tuesday, August 13, 2024
HC Wainwright & Co. Reiterates Buy on ALX Onc...
Benzinga Newsdesk
Monday, August 12, 2024
Cantor Fitzgerald Reiterates Overweight on AL...
Benzinga Newsdesk
Friday, August 09, 2024
Stifel Reiterates Hold on ALX Oncology Holdin...
Benzinga Newsdesk
Thursday, August 08, 2024
ALX Oncology Holdings Q2 EPS $(0.76) Beats $(...
Benzinga Newsdesk
Thursday, August 01, 2024
Crude Oil Moves Lower; Moderna Shares Plunge
Avi Kapoor
Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July
Avi Kapoor
Stifel Maintains Hold on ALX Oncology Holding...
Benzinga Newsdesk
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
Avi Kapoor
Immuno-Oncology Focused ALX Oncology Stock Falls On Updated Data From Mid-Stage Evorpacept Combo Study In Gastric Cancer Patients
Vandana Singh
HC Wainwright & Co. Reiterates Buy on ALX Onc...
Benzinga Newsdesk
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Market-Moving News for August 1st
Benzinga Newsdesk
ALX Oncology Holdings shares are trading lowe...
Benzinga Newsdesk
Wednesday, July 31, 2024
Trading Halt: Halt status updated at 4:25:00 ...
Benzinga Newsdesk
ALX Oncology Reports Data From ASPEN-06 Phase...
Benzinga Newsdesk
Trading Halt: Halted at 4:00:10 p.m. ET - Tra...
Benzinga Newsdesk
ALX Oncology shares are trading lower. The co...
Benzinga Newsdesk
ALX Oncology to Announce Phase 2 Trial Result...
Benzinga Newsdesk
Wednesday, July 10, 2024
UniQure Soars on New Huntington's Disease Study Data
Zacks
Tuesday, July 02, 2024
Mesoblast Soars 208% YTD on Positive Regulatory Updates
Zacks
Friday, June 28, 2024
Denali Outperforms Industry in 3 Months: Here's Why
Zacks
Thursday, June 27, 2024
Novo Nordisk's Hypertension Drug Study Fails to Meet Goal
Zacks
Wednesday, June 26, 2024
Roche's Ocrevus Subcutaneous Gets European Commission Nod
Zacks
Friday, June 21, 2024
Gilead Up as Twice-Yearly HIV Shot Prevents Infection
Zacks
Monday, June 10, 2024
Moderna Submits Updated COVID-19 Jab to FDA for Review
Zacks
HC Wainwright & Co. Reiterates Buy on ALX Onc...
Benzinga Newsdesk
Thursday, June 06, 2024
Halozyme's ENHANZE Product Gets New Patent Grant in EU
Zacks
Tuesday, June 04, 2024
Intellia Up on Upbeat Long-Term Angioedema Study Data
Zacks
Monday, June 03, 2024
AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks
Sunday, June 02, 2024
ALX Oncology Reported Phase 1 ASPEN-07 Data In in Patients with Advanced Bladder Cancer AT ASCO 2024; Initial Activity Showed Tumor Reduction In The Majority Of Evaluable Patients
Charles Gross
Wednesday, May 29, 2024
Cantor Fitzgerald Reiterates Overweight on AL...
Benzinga Newsdesk
Thursday, May 23, 2024
Bristol Myers Updates Action Date for Subcutaneous Opdivo
Zacks
Thursday, May 09, 2024
ALX Oncology Holdings Q1 EPS $(0.71)
Benzinga Newsdesk
Tuesday, April 30, 2024
ALX Oncology Announces Initiation Of Phase 2 ...
Benzinga Newsdesk
Wednesday, April 17, 2024
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Friday, April 12, 2024
Cantor Fitzgerald Reiterates Overweight on AL...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch